RhumbLine Advisers’s Definitive Healthcare DH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $245K | Sell |
62,705
-13,923
| -18% | -$54.3K | ﹤0.01% | 3115 |
|
|
2025
Q1 | $221K | Sell |
76,628
-4,688
| -6% | -$13.5K | ﹤0.01% | 3059 |
|
|
2024
Q4 | $334K | Buy |
81,316
+4,034
| +5% | +$16.6K | ﹤0.01% | 2925 |
|
|
2024
Q3 | $345K | Sell |
77,282
-6,469
| -8% | -$28.9K | ﹤0.01% | 2952 |
|
|
2024
Q2 | $457K | Buy |
83,751
+13,764
| +20% | +$75.2K | ﹤0.01% | 2748 |
|
|
2024
Q1 | $565K | Buy |
69,987
+1,804
| +3% | +$14.6K | ﹤0.01% | 2591 |
|
|
2023
Q4 | $678K | Buy |
68,183
+1,959
| +3% | +$19.5K | ﹤0.01% | 2489 |
|
|
2023
Q3 | $529K | Buy |
66,224
+2,110
| +3% | +$16.9K | ﹤0.01% | 2583 |
|
|
2023
Q2 | $705K | Buy |
64,114
+31,328
| +96% | +$345K | ﹤0.01% | 2482 |
|
|
2023
Q1 | $339K | Buy |
32,786
+1,055
| +3% | +$10.9K | ﹤0.01% | 2575 |
|
|
2022
Q4 | $349K | Sell |
31,731
-2,576
| -8% | -$28.3K | ﹤0.01% | 2612 |
|
|
2022
Q3 | $533K | Buy |
34,307
+6,584
| +24% | +$102K | ﹤0.01% | 2470 |
|
|
2022
Q2 | $636K | Buy |
27,723
+16,650
| +150% | +$382K | ﹤0.01% | 2363 |
|
|
2022
Q1 | $273K | Sell |
11,073
-2,061
| -16% | -$50.8K | ﹤0.01% | 2669 |
|
|
2021
Q4 | $359K | Buy |
+13,134
| New | +$359K | ﹤0.01% | 2643 |
|